Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial - SELECT TDCS: Design, rationale and objectives

Contemporary Clinical Trials

Volumn 32, Issue 1, 2011, Pages 90-98

  Brunoni, Andre Russowsky ^a   Valiengo, Leandro ^a   Baccaro, Alessandra ^a   Zanao, Tamires Araujo ^a   de Oliveira, Janaina Farias ^a   Vieira, Giselly Pereira ^a   Bueno, Viviane Freire ^a   Goulart, Alessandra C ^a   Boggio, Paulo Sérgio ^b   Lotufo, Paulo Andrade ^a   Bensenor, Isabela Martins ^a   Fregni, Felipe ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

^c and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

Author keywords

Antidepressive agents; Clinical trial; Electric stimulation therapy; Factorial design; Major depressive disorder

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PLACEBO; SERTRALINE;

ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ELECTROSTIMULATION THERAPY; GENETIC POLYMORPHISM; HAMILTON SCALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROPSYCHOLOGICAL TEST; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESEARCH SUBJECT; TRANSCRANIAL DIRECT CURRENT STIMULATION; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CEREBRAL CORTEX; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION THERAPY; HUMANS; RESEARCH DESIGN; SERTRALINE; TREATMENT OUTCOME;

EID: 78649905804     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2010.09.007     Document Type: Article

References (66)

1. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
2. Andrade L., Caraveo-Anduaga J.J., Berglund P., Bijl R.V., De Graaf R., Vollebergh W., et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res 2003, 12:3-21.
3. Simon G.E., Fleck M., Lucas R., Bushnell D.M. Prevalence and predictors of depression treatment in an international primary care study. Am J Psychiatry 2004, 161:1626-1634.
4. Berlim M.T., Turecki G. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 2007, 52:46-54.
5. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006, 163:1905-1917.
6. Brunoni A.R., Fraguas R., Fregni F. Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability. Ther Clin Risk Manag 2009, 5:897-910.
7. Nakajima S., Suzuki T., Watanabe K., Kashima H., Uchida H. Accelerating response to antidepressant treatment in depression: a review and clinical suggestions. Prog Neuropsychopharmacol Biol Psychiatry 2009.
8. Fregni F., Boggio P.S., Nitsche M., Pascual-Leone A. Transcranial direct current stimulation. Br J Psychiatry 2005, 186:446-447.
9. Nitsche M.A., Cohen L.G., Wassermann E.M., Priori A., Lang N., Antal A., et al. (2008) Transcranial direct current stimulation: state of the art. BRAIN STIMUL 2008, 1:206-223.
10. Koenigs M., Grafman J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res 2009, 201:239-243.
11. Priori A., Hallett M., Rothwell J.C. Repetitive transcranial magnetic stimulation or transcranial direct current stimulation?. Brain Stimul 2009, 2:241-245.
12. Fregni F., Boggio P.S., Nitsche M.A., Marcolin M.A., Rigonatti S.P., Marcolin M.A., et al. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord 2006, 8:203-204.
13. Boggio P.S., Rigonatti S.P., Ribeiro R.B., Myczkowski M.L., Nitsche M.A., Pascual-Leone A., et al. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol 2008, 11:249-254.
14. Rigonatti S.P., Boggio P.S., Myczkowski M.L., Otta E., Fiquer J.T., Ribeiro R.B., et al. Transcranial direct stimulation and fluoxetine for the treatment of depression. Eur Psychiatry 2008, 23:74-76.
15. Loo C.K., Sachdev P., Martin D., Pigot M., Alonzo A., Malhi G.S., et al. A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol 2009, 1-9.
16. Tint A., Haddad P.M., Anderson I.M. The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study. J Psychopharmacol 2008, 22:330-332.
17. Brunoni A.R., Lopes M., Kaptchuk T.J., Fregni F. Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis. PLoS ONE 2009, 4:e4824.
18. Cipriani A., La Ferla T., Furukawa T.A., Signoretti A., Nakagawa A., Churchill R., et al. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev 2010, 4:CD006117.
19. Schutter D.J. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med 2009, 39:65-75.
20. Rumi D.O., Gattaz W.F., Rigonatti S.P., Rosa M.A., Fregni F., Rosa M.O., et al. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry 2005, 57:162-166.
21. Rossini D., Magri L., Lucca A., Giordani S., Smeraldi E., Zanardi R. Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. J Clin Psychiatry 2005, 66:1569-1575.
22. Herwig U., Fallgatter A.J., Hoppner J., Eschweiler G.W., Kron M., Hajak G., et al. Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. Br J Psychiatry 2007, 191:441-448.
23. Ferrucci R., Bortolomasi M., Vergari M., Tadini L., Salvoro B., Giacopuzzi M., et al. Transcranial direct current stimulation in severe, drug-resistant major depression. J Affect Disord 2009, 118:215-219.
24. Gandiga P.C., Hummel F.C., Cohen L.G. Transcranial DC stimulation (tDCS): a tool for double-blind sham-controlled clinical studies in brain stimulation. Clin Neurophysiol 2006, 117:845-850.
25. Ambrus G.G., Paulus W., Antal A. Cutaneous perception thresholds of electrical stimulation methods: comparison of tDCS and tRNS. Clin Neurophysiol 2010, 121:1908-1914.
26. Cipriani A., Furukawa T.A., Salanti G., Geddes J.R., Higgins J.P., Churchill R., et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009, 373:746-758.
27. Bauer M., Whybrow P.C., Angst J., Versiani M., Moller H.J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 2002, 3:5-43.
28. Higgins J., Green S. Cochrane handbook for systematic reviews of interventions version 5.0.2. (updated september 2009). The Cochrane Collaboration 2008, Available from www.cochrane-handbook.org.
29. Gorenstein C., Andrade L.H.S.G., Zuardi A.W. Escalas de Avaliação Clínica em Psiquiatria e Psicofarmacologia 2000, Sao Paulo.
30. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
31. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53:695-699.
32. Benedict R.H., Schretlen D., Groninger L., Dobraska M., Shpritz B. Revision of the brief visuospatial memory test: studies of normal performance, reliability and validity 1996, 8:145-153.
33. Golden C.J. Stroop color and word test 1978, Stoelting, Chicago (IL).
34. Moses J.A. Test review-Comprehensive Trail Making Test (CTMT). Arch Clin Neuropsychol 2004, 19:703-708.
35. Rabkin J.G., Markowitz J.S., Ocepek-Welikson K., Wager S.S. General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research. J Clin Psychopharmacol 1992, 12:3-10.
36. Poreisz C., Boros K., Antal A., Paulus W. Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull 2007, 72:208-214.
37. Gelenberg A.J., Thase M.E., Meyer R.E., Goodwin F.K., Katz M.M., Kraemer H.C., et al. The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. J Clin Psychiatry 2008, 69:1513-1528.
38. Moller H.J. Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales. World J Biol Psychiatry 2009, 10:6-26.
39. Trivedi M.H., Fava M., Wisniewski S.R., Thase M.E., Quitkin F., Warden D., et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006, 354:1243-1252.
40. O'Reardon J.P., Cristancho P., Pilania P., Bapatla K.B., Chuai S., Peshek A.D. Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion. Depress Anxiety 2007, 24:537-544.
41. Boggio P.S., Ferrucci R., Rigonatti S.P., Covre P., Nitsche M., Pascual-Leone A., et al. Effects of transcranial direct current stimulation on working memory in patients with Parkinson's disease. J Neurol Sci 2006, 249:31-38.
42. Iyer M.B., Mattu U., Grafman J., Lomarev M., Sato S., Wassermann E.M., et al. Safety and cognitive effect of frontal DC brain polarization in healthy individuals. Neurology 2005, 64:872-875.
43. Monte-Silva K.K., Kuo M.F., Liebetanz D., Paulus W., Nitsche M.A. Shaping the optimal repetition interval for cathodal transcranial direct current stimulation (tDCS). J Neurophysiol 2010.
44. Grimm S., Beck J., Schuepbach D., Hell D., Boesiger P., Bermpohl F., et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry 2008, 63:369-376.
45. George M.S., Aston-Jones G. Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology 2010, 35:301-316.
46. Arul-Anandam A.P., Loo C., Mitchell P. Induction of hypomanic episode with transcranial direct current stimulation. J ECT 2010, 26:68-69.
47. Baccaro A., Brunoni A.R., Bensenor I.M., Fregni F. Hypomanic episode in unipolar depression during transcranial direct current stimulation. Acta Neuropsychiatrica 2010, 22:316-318.
48. Brunoni AR, Valiengo L, Zanao T, Oliveira J, Bensenor IM, Fregni F, et al. Manic psychosis following transcranial direct current stimulation and sertraline. The Journal of Neuropsychiatry and Clinical Neurosciences. in press.
49. Demirtas-Tatlidede A., Mechanic-Hamilton D., Press D.Z., Pearlman C., Stern W.M., Thall M., et al. An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients. J Clin Psychiatry 2008, 69:930-934.
50. Taylor M.J., Freemantle N., Geddes J.R., Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry 2006, 63:1217-1223.
51. Papakostas G.I., Perlis R.H., Scalia M.J., Petersen T.J., Fava M. A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder. J Clin Psychopharmacol 2006, 26:56-60.
52. Walsh B.T., Seidman S.N., Sysko R., Gould M. Placebo response in studies of major depression: variable, substantial, and growing. Jama 2002, 287:1840-1847.
53. Fregni F., Ono C.R., Santos C.M., Bermpohl F., Buchpiguel C., Barbosa E.R., et al. Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD. Neurology 2006, 66:1629-1637.
54. Kaptchuk T.J., Kelley J.M., Conboy L.A., Davis R.B., Kerr C.E., Jacobson E.E., et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. Bmj 2008, 336:999-1003.
55. Bares M., Kopecek M., Novak T., Stopkova P., Sos P., Kozeny J., et al. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study. J Affect Disord 2009.
56. Brunoni AR, Fregni F. Clinical Trial Design in Noninvasive Brain Stimulation Psychiatric Research. International Journal of Methods in Psychiatry Research. in press.
57. Stagg C.J., Best J.G., Stephenson M.C., O'Shea J., Wylezinska M., Kincses Z.T., et al. Polarity-sensitive modulation of cortical neurotransmitters by transcranial stimulation. J Neurosci 2009, 29:5202-5206.
58. Rango M., Cogiamanian F., Marceglia S., Barberis B., Arighi A., Biondetii P., et al. Myoinositol content in the human brain is modified by transcranial direct current stimulation in a matter of minutes: a 1H-MRS study. Magn Reson Med 2008, 60:782-789.
59. Allen S.J., Dawbarn D. Clinical relevance of the neurotrophins and their receptors. Clin Sci (Lond) 2006, 110:175-191.
60. Brunoni A.R., Lopes M., Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 2008, 11:1169-1180.
61. Frodl T., Moller H.J., Meisenzahl E. Neuroimaging genetics: new perspectives in research on major depression?. Acta Psychiatr Scand 2008, 118:363-372.
62. Ozan E., Okur H., Eker C., Eker O.D., Gonul A.S., Akarsu N. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Res Bull 2010, 81:61-65.
63. Cheeran B., Talelli P., Mori F., Koch G., Suppa A., Edwards M., et al. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol 2008, 586:5717-5725.
64. Kemp A.H., Quintana D.S., Gray M.A., Felmingham K.L., Brown K., Gatt J.M. Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis. Biol Psychiatry 2010, 11:1067-1074.
65. Licht C.M., de Geus E.J., Zitman F.G., Hoogendijk W.J., van Dyck R., Penninx B.W., et al. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry 2008, 65:1358-1367.
66. van Zyl L.T., Hasegawa T., Nagata K. Effects of antidepressant treatment on heart rate variability in major depression: a quantitative review. Biopsychosoc Med 2008, 2:12.